Peripheral Arterial Disease Trial, Recruiting (NCT07427108)

Peripheral Arterial Disease Trial, Recruiting NCT07427108 Sponsor: Sohag University Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07427108 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults of any gender are eligible to participate.
People who have been diagnosed with a serious condition called critical limb-threatening ischemia (CLTI), which means poor blood flow in the leg causing non-healing wounds or ulcers (confirm with trial site for full classification details).
People whose doctors were unable to access the affected blood vessel using the standard approach and who require an alternative access point, entering from a lower part of the leg going upward.
People who are planned to have a minimally invasive procedure to open blocked blood vessels, such as balloon widening of an artery or placement of a small tube to keep it open.

Who may not be able to join:

People who have an active infection in the area where the needle would be inserted, particularly around the ankle region.
People whose arteries have very heavy calcium buildup or unusual structural changes that would make the procedure unsafe to perform using the required access method.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +201288374728

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07427108

Sponsor: Sohag University

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: +201288374728

More information: https://clinicaltrials.gov/study/NCT07427108

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults of any gender are eligible to participate.
People who have been diagnosed with a serious condition called critical limb-threatening ischemia (CLTI), which means poor blood flow in the leg causing non-healing wounds or ulcers (confirm with trial site for full classification details).
People whose doctors were unable to access the affected blood vessel using the standard approach and who require an alternative access point, entering from a lower part of the leg going upward.
People who are planned to have a minimally invasive procedure to open blocked blood vessels, such as balloon widening of an artery or placement of a small tube to keep it open.

Who may not be able to join:

People who have an active infection in the area where the needle would be inserted, particularly around the ankle region.
People whose arteries have very heavy calcium buildup or unusual structural changes that would make the procedure unsafe to perform using the required access method.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sohag University

Registry

ClinicalTrials.gov

Start date

1 February 2026

Est. completion

31 December 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Success rate; Complication rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov